Prevent Delirium
Using Artificial Intelligence for better Patient Outcomes
Delirium
Delirium Leads To
6x Nursing home admissions
14x Risk of dementia
7.4m EUR Average annual cost per hospital
Average length of stay increased by 3 days
Identify Patients with PIPRA
Identify and treat high-risk patients with multi component intervention bundle. Get the benefits:
- Secure web solution
- High performance
- No device required
- CE-marked
- Pay per use
- No installation required
- Flexible integration (0-100%)
- Patient data protected
- Delirium prevention support bundle included
- Risk assessment in <2 min

Medically Approved in EU (CE-certified)
Medically approved & reimbursed in:
- Switzerland
- Austria
- Finland
- Ireland
- Germany
- Belgium
- Sweden
- Portugal
- France
- The Netherlands
- Spain
- Estonia

Testimonials
Our Publications

Want to contact us?
PIPRA AG has developed a cutting-edge AI-based pre-operative risk assessment tool called PIPRA (short for Pre-Interventional Preventive Risk Assessment), to assess the risk of a patient developing POD. The test uses standard medical data, is web-or app-based, and takes less than two minutes to provide a score-based risk assessment. This risk assessment enables doctors, nurses and health services to better personalise their patient’s operative plan and to introduce key clinical interventions to reduce the patient’s risk of developing POD.